Maarten Versteven

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

Journal: Experimental hematology & oncology

Published: December 18, 2025

A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens.

A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens.

Journal: Frontiers in immunology

Published: June 06, 2024

Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells.

Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells.

Journal: Methods in cell biology

Published: March 28, 2024

Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.

Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.

Journal: Annals of hematology

Published: March 14, 2024

In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.

In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.

Journal: STAR protocols

Published: October 13, 2022

Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands.

Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands.

Journal: Frontiers in immunology

Published: June 30, 2021

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

Journal: Pharmaceutics

Published: January 19, 2021

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA.

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA.

Journal: Cancers

Published: December 21, 2019

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?

Journal: Cancers

Published: November 06, 2019

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15.

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15.

Journal: Cancers

Published: July 08, 2019

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.

Journal: Journal of clinical medicine

Published: March 21, 2019

The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.

The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.

Journal: Cytokine & growth factor reviews

Published: April 21, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026